Finance

Parvus Therapeutics and Genentech have forged a global collaboration and license agreement to develop, manufacture and commercialise novel Navacim therapeutics for treating inflammatory bowel...

Thermo Fisher Scientific is acquiring a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline for €90 million. The Cork site will expand capacity to...

GSK has expanded its licensing and collaboration agreement with Canadian biopharma Zymeworks. Originally struck back in 2016, the agreement pooled both companies’ collective know-how to...